Iovance Biotherapeutics Inc
(IOVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 67,455 | 59,952 | 49,324 | 73,694 | 58,555 |
| Cost of Goods | 38,477 | 56,664 | 49,741 | 53,848 | 31,518 |
| Gross Profit | 28,978 | 3,288 | -417 | 19,846 | 27,037 |
| Operating Expenses | 124,356 | 117,726 | 121,545 | 107,270 | 116,621 |
| Operating Income | -94,901 | -113,774 | -121,221 | -86,576 | -89,066 |
| Other Income | 1,243 | 4,104 | 3,220 | 9,575 | 4,005 |
| Pre-tax Income | -93,658 | -109,670 | -118,001 | -77,001 | -85,061 |
| Income Tax | -2,405 | 1,988 | -1,838 | 1,558 | -1,520 |
| Net Income Continuous | -91,253 | -111,658 | -116,163 | -78,559 | -83,541 |
| Net Income | $-91,253 | $-111,658 | $-116,163 | $-78,559 | $-83,541 |
| EPS Basic Total Ops | -0.25 | -0.33 | -0.36 | -0.24 | -0.28 |
| EPS Basic Continuous Ops | -0.25 | -0.33 | -0.36 | -0.24 | -0.28 |
| EPS Diluted Total Ops | -0.25 | -0.33 | -0.36 | -0.24 | -0.28 |
| EPS Diluted Continuous Ops | -0.25 | -0.33 | -0.36 | -0.24 | -0.28 |
| EPS Diluted Before Non-Recurring Items | -0.25 | -0.33 | -0.36 | -0.26 | -0.28 |
| EBITDA(a) | $-84,935 | $-103,839 | $-112,302 | $-76,649 | $-81,585 |